Susquehanna Portfolio Strategies’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-277,108
Closed -$28.1M 1020
2025
Q4
$28.1M Hold
277,108
0.43% 56
2025
Q3
$15.2M Buy
277,108
+231,408
+506% +$11.6M 0.24% 115
2025
Q2
$2.43M Buy
+45,700
New +$2.32M 0.05% 333
2024
Q1
Sell
-25,676
Closed -$1.9M 843
2023
Q4
$1.9M Buy
+25,676
New +$1.68M 0.03% 445

Other funds holding EXAS

Susquehanna Portfolio Strategies's EXAS Position: Q1 2026 in Review

Susquehanna Portfolio Strategies sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 277,108 shares — an estimated $28.1M sold.

Susquehanna Portfolio Strategies first reported a position in EXAS in Q4 2023 and held it in 4 quarters. The position peaked at $28.1M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Susquehanna Portfolio Strategies reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 277,108 Exact Sciences shares in Q1 2026, an estimated $28.1M.
  • Susquehanna Portfolio Strategies first reported a position in Exact Sciences in Q4 2023 and held it in 4 quarters.
  • Susquehanna Portfolio Strategies's Exact Sciences position peaked at $28.1M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.